Responsibilities: Clinical Trial Support ā¢ Develop, maintain, manage, and link relationships within investigational sites and across relevant referral networks to increase awareness of the clinical trial to maximize their success in reaching their enrollment goals; ā¢ Drive identification of potential sites and investigators for clinical trials; ā¢ In collaboration with the Clinical Development and Operations teams, support clinical study feasibility and effective study implementation; ā¢ Enhance clinical operations efforts to support and/or improve recruitment & retention by possible education, training, clinical discussions with clinical research/investigatorās team; ā¢ Support the development of patient referral network within the geographic area; ā¢ Identify effective prescreening strategies for each trial and recommend improvements; ā¢ Work with study team to develop, plan, and execute strategies that will increase enrollment at the clinical trial site level; ā¢ Support the Development CNS Center Of Excellence Map considering key criteria including KOLs/TLs, geographic footprint, referral network, capacity and infrastructure. External Engagement & Development ā¢ Establish a network of KOLs focused on clinical management of conditions in companyās therapeutic areas of interest; ā¢ Identify new KOL/HCPs for future engagement, including but not limited to identification of new clinical researcher, scientific advisors, and medical educators; ā¢ Collect medical insights and intelligence gathered from scientific exchange with clinical investigators and non-investigator thought leaders; ā¢ Attend and support key Medical/Scientific meetings to make contacts, evaluate the field and obtain ideas for improvements in trial design and conduct, trial awareness and patient recruitment/retention initiatives; ā¢ As required support Therapeutic Area Scientific/Clinical National and Regional Advisory Board meetings; ā¢ In collaboration with the Director patient advocacy and Sr Director Medical Affairs and Therapeutic Area Lead support Patient Advocacy initiatives in alignment with program and product strategies; ā¢ Cross-functionally identity feasibility and interest of investigators interested in Investigator Initiated Studies (IIS) in alignment with the asset and pipeline.